Home NDC 0006-3823 CANCIDAS
Product NDC 0006-3823
11-digit product format 000063823
Labeler code 0006
Product ID 0006-3823_415db552-7a2f-4881-9545-b7dd64816003
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CASPOFUNGIN ACETATE
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Merck Sharp & Dohme LLC
Application NDA021227
Marketing category NDA
Marketing start 2001-01-26
Substance CASPOFUNGIN ACETATE
Active strength 7 mg/mL
Pharmacologic classes Echinocandin Antifungal [EPC], Lipopeptides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021227-001 CANCIDAS CASPOFUNGIN ACETATE 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 N021227-002 CANCIDAS CASPOFUNGIN ACETATE 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 68 observed states.
Additional Listing Data#
Finished product Yes
Brand name base CANCIDAS
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CASPOFUNGIN ACETATE 7 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination VUW370O5QE Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 828539 Internal RxNorm lookup 828541 Internal RxNorm lookup 828755 Internal RxNorm lookup 828757 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0006-3823-10 CANCIDAS 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 41 0006-3823-10 CANCIDAS 10.8 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 10.8 41
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CASPOFUNGIN ACETATE ACTIVE INGREDIENT VUW370O5QE CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 CASPOFUNGIN ACTIVE MOIETY F0XDI6ZL63 CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 ACETIC ACID INACTIVE INGREDIENT Q40Q9N063P CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 MANNITOL INACTIVE INGREDIENT 3OWL53L36A CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 SUCROSE INACTIVE INGREDIENT C151H8M554 CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0006-3823 CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME LLC] 40 Current NDC, Legacy NDC, 2 package rows 20241018_3bad23a6-09a6-4194-9182-093ed61bc71c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0006-3823-10 00006382310 1 VIAL, SINGLE-USE in 1 CARTON (0006-3823-10) / 10.8 mL in 1 VIAL, SINGLE-USE 2001-01-26 0000-00-00 No No Current